Technical Analysis for PRVB - Provention Bio, Inc.

Grade Last Price % Change Price Change
grade B 11.852 -2.53% -0.31
PRVB closed down 3.03 percent on Tuesday, June 25, 2019, on 63 percent of normal volume.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical PRVB trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction -2.53%
Wide Bands Range Expansion -2.53%
Wide Bands Range Expansion -5.49%
Wide Bands Range Expansion -3.41%
1,2,3 Pullback Bullish Bullish Swing Setup 8.14%
Boomer Buy Setup Bullish Swing Setup 8.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 8.14%
Narrow Range Bar Range Contraction 8.14%
NR7 Range Contraction 8.14%
NR7-2 Range Contraction 8.14%

Older signals for PRVB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
Medicine Biopharmaceutical Medical Specialties Immunology Disease Diabetes Autoimmune Diseases Ulcerative Colitis Abdominal Pain Diarrhea Crohn's Disease Viral Diseases Colitis Lupus Immune Mediated Diseases
Is PRVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 24 68 Biggest Movers From Friday
Jun 19 Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data
Jun 14 Provention Bio: The Panacea For Diabetes
Jun 14 Why Consistent Trading Doesn't Always Lead To Consistent Results
Jun 13 CHK, DRYS among premarket gainers
Jun 13 Provention Bio Cancels Secondary Offering, Shares Rally
Jun 13 Provention Bio's stock surges after calling off public stock offering
Jun 13 Provention Bio bails on IPO
Jun 13 Provention Bio Announces Termination of Public Offering of Common Stock
Jun 12 2 Small Biotechs With Sagging Shares but Promising Prospects
See more PRVB news...
Indicators
Indicator Value
52 Week High 22.82
52 Week Low 1.52
Average Volume 993,783
200-Day Moving Average 3.487
50-Day Moving Average 5.6567
20-Day Moving Average 8.786
10-Day Moving Average 11.588
Average True Range 1.562
ADX 63.63
+DI 51.4384
-DI 6.725
Chandelier Exit (Long, 3 ATRs ) 18.134
Chandelier Exit (Short, 3 ATRs ) 8.4106
Upper Bollinger Band 16.3007
Lower Bollinger Band 1.2713
Percent B (%b) 0.72
BandWidth 171.060779
MACD Line 2.1237
MACD Signal Line 1.9398
MACD Histogram 0.1839
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.60
Resistance 3 (R3) 13.70 13.33 13.36
Resistance 2 (R2) 13.33 12.97 13.28 13.28
Resistance 1 (R1) 12.75 12.74 12.56 12.64 13.20
Pivot Point 12.37 12.37 12.28 12.32 12.37
Support 1 (S1) 11.79 12.01 11.60 11.68 11.12
Support 2 (S2) 11.42 11.78 11.36 11.04
Support 3 (S3) 10.83 11.42 10.96
Support 4 (S4) 10.72